Yi-jie Ma

Network pharmacology and molecular docking analysis reveal insights into the molecular mechanism of shiliao decoction in the treatment of cancer-associated malnutrition

H. Xie, Shuangshuang Ji, Shijie Zhu, 2022, Frontiers in Nutrition.

A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma

Y. Cheng, B. Tan, L. Bie, 2022, BMC medicine.

Decreased expression of miR-542-3p exerts growth inhibitory functions in esophageal cancer.

Xiao-Bing Chen, Bei-bei Chen, L. Bie, 2015, Journal of Cancer Research and Therapeutics.